Shotaro Tatekawa
Papers
1
Total Citations
7
H-Index
1
About
Shotaro Tatekawa is a radiation oncologist whose research centers on stereotactic ablative body radiotherapy (SABR), particularly for metastatic lung tumors. His most cited work, a 2023 study on CyberKnife-based SABR, demonstrates a novel approach that leverages the system's robotic precision to deliver a high central dose while maintaining steep dose gradients—a technique that enhances tumor control while sparing surrounding healthy tissue. This contribution is critical for treating central lung metastases, where conventional radiotherapy risks toxicity. With 7 citations already, this paper signals growing interest in dose-escalation strategies within SABR. Beyond this, Tatekawa's broader research explores real-time image-guided radiotherapy and dose optimization, aiming to push the boundaries of non-invasive cancer treatment. His work exemplifies how technological innovation in radiation delivery can translate into safer, more effective patient outcomes. For students and researchers, Tatekawa's focus on precision radiotherapy offers a compelling model of how engineering and clinical oncology intersect to solve real-world challenges in metastatic disease management.
Research Focus
Key Achievements
Top Papers
- 1